Lorrain Daniel S. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lorrain Daniel S.（CIK 1861550）在 1 家公司共报告 27 笔 SEC Form 4 内部人交易（最近一笔 2026-07-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 1,015 | $1,025 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 1,015 | $16,240 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 25 | $25 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 25 | $400 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 5,852 | $91,682 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 28,826 | $462,288 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 4,183 | $4,225 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 28,826 | $29,114 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 2,501 | $40,608 |
| 2026-06-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 4,170 | $54,877 |
| 2026-05-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 3,870 | $50,542 |
| 2026-05-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 300 | $4,152 |
| 2026-04-06 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 4,170 | $56,003 |
| 2026-03-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 4,170 | $62,592 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 4,300 | $4,343 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 4,300 | $68,929 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 3,824 | $3,862 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 3,824 | $61,222 |
| 2026-02-20 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 100 | $101 |
| 2026-02-20 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 100 | $1,600 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 买入 | 400 | $404 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 400 | $6,400 |
| 2026-02-05 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 3,000 | $44,460 |
| 2026-02-05 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 1,170 | $17,842 |
| 2026-01-06 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | 卖出 | 3,670 | $37,984 |
来源：SEC Form 4 申报文件 · 截至 2026-07-10